Contract Manufacturers in MA
A cGMP and ISO 13485 compliant company.
A gloval contract research and manufacturing offering fully integrated drug discovery, development, and manufacturing services.
FDA-inspected facility to manufacture active pharmaceutical ingredients (API) that meet the international requirements of ICH Q7.
Produces more than 180 billion capsules annually.
Provider of outsourced pharmaceutical manufacturing services.
A fully integrated cGMP/GLP contract chemistry organization, FDA registered and DEA licensed.
Engaged in the research, development and manufacture of specific chemicals for biotechnology and pharmaceutical industries.
DEA scheduled 1-5 for analytic lab and 2-5 for R &D projects both under cGMP conditions.
Capabilities for mammalian cell culture and protein purification in both perfusion and fed batch mode.
Synthesis of organic/medicinal compounds of all classes.
Advanced flow chemistry technology and processes bring quality and efficiency to every stage of production.
Leading contract manufacturer of therapeutic monoclonal antibodies and recombinant proteins derived from mammalian cell culture.
An FDA registered, ISO 9001, ISO/IEC 17025 certified facility, small scale aseptic fill/finish manufacturing, assays and manufacturing are conducted in accordance with ISO, AAMI, USP, and EP.
cGMP facility offers contract and private-label manufacturing services to firms seeking fully-validated, aseptic processing and testing of pharmaceuticals in either liquid or lyophilized form.
Custom synthesis and small scale manufacturing.
FDA inspected manufacturer of new chemical entities (NCEs), generic APIs, and other formulated pharmaceutical and chemical products.
Biochemicals, antibodies, recombinant proteins, cell culture media and molecular biology kits.
Built around a unique biomanufacturing platform that features single use technology.
MassBio is a not-for-profit organization committed to advancing the development of critical new science, technology and medicines that benefit people worldwide.
Founded in 1985, MassBio represents over 600 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and health care, and works to advance policy and promote education, while providing member programs and events, industry information, and services.
- January 30, 2015 Biomarkers Part I: Basic Concepts of Biomarkers, Discovery and Identification
- January 30, 2015 Difficult Conversations: The Biotech Industry
- January 30, 2015 State of Rare: Taking Stock of Rare Disease Research Today & Tomorrow
- January 26, 2015 MassBio Office Closed 1/27 & 1/28, Policy Breakfast Postponed Due to Blizzard
- January 23, 2015 Supporting Increased NIH Funding